Cardiovascular Drug Development: Protocol Design and Methodology - Couverture rigide

 
9780824719272: Cardiovascular Drug Development: Protocol Design and Methodology
Couverture rigide
ISBN 10 : 0824719271 ISBN 13 : 9780824719272
Editeur : CRC Press Inc, 1998

Synopsis

These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process.
Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employed in the creation of vital new cardiovascular therapies!
Cardiovascular Drug Development

  • explores the delicate balance of efficacy and safety that cardiovascular therapy must achieve to gain regulatory approval
  • discusses the search for surrogates and the need in some areas for natural history endpoints
  • reviews optimum strategies for protocol design in the development of drugs to treat hypertension, cardiac arrhythmias, heart failure, coronary artery disease, and hypercholesterolemia and other lipid disorders
  • compares and contrasts the varying standards of evidence for drug approval in the United States, Europe, and Asia
  • and more!
    Cardiovascular Drug Development will prove to be a valuable asset for cardiologists, pharmacologists and pharmacists, regulatory affairs specialists, and directors of research and development for pharmaceutical companies.

    • Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

    Présentation de l'éditeur

    These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process.
    Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employed in the creation of vital new cardiovascular therapies!
    Cardiovascular Drug Development

  • explores the delicate balance of efficacy and safety that cardiovascular therapy must achieve to gain regulatory approval
  • discusses the search for surrogates and the need in some areas for natural history endpoints
  • reviews optimum strategies for protocol design in the development of drugs to treat hypertension, cardiac arrhythmias, heart failure, coronary artery disease, and hypercholesterolemia and other lipid disorders
  • compares and contrasts the varying standards of evidence for drug approval in the United States, Europe, and Asia
  • and more!
    Cardiovascular Drug Development will prove to be a valuable asset for cardiologists, pharmacologists and pharmacists, regulatory affairs specialists, and directors of research and development for pharmaceutical companies.

    • Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

    Éditeur
    CRC Press Inc
    Date d'édition
    1998
    Langue
    anglais
    ISBN 10 
    0824719271
    ISBN 13 
    9780824719272
    Reliure
    Relié
    Nombre de pages
    248
    Éditeur
    Borer Jeffrey S., Somberg John C. M.D., Borer J. S.
    Coordonnées du fabricant
    non disponible
    Personne responsable
    non disponible